With their eclectic mix of mutations, tumors often survive drug treatment. In a new study, researchers found a way to use cancer’s evolutionary potential against it, destroying drug-resistant tumors in animals.
More by Jonathan Griffin
NIBIB bioengineer Kaitlyn Sadtler has flourished as a leader of many impactful, interdisciplinary studies. For her role in shaping the future of medical research, TIME magazine has named Kaitlyn Sadtler to the TIME100 Next 2024 List.
Cancer cells frequently overhaul their surroundings, making tumors stiffer than nearby healthy tissue. While tumor stiffening makes some cancers easier to detect, it can also ramp up drug resistance. New research suggests that these detrimental changes are not set in stone, however.
Physical human feats require a high level of coordination between sensory and motor functions. What kind of achievements could robots perform with the same cohesion between sensing and action? In the medical space, researchers have begun to explore the possibilities.
Due to its high accuracy, lab-based PCR testing is the gold standard for infectious disease diagnostics. Yet PCR's availability is limited, especially in low-resource settings. New research suggests a new kind of test could be more streamlined without sacrificing performance.
Researchers have established an RNA-based method that drives cells in the body to produce therapeutic proteins and secrete them into the bloodstream. The approach could extend the lifespan of drugs in the body, reducing the burden on patients.
Diabetic wounds are slow-healing, potentially life-threatening complications with limited treatment options. But a two-step, nanomaterial-based strategy may open doors to better care.
Measuring heart rate or body temperature may sound easy, but retrieving the data from small animals with bulky traditional tech is difficult, especially during behavioral tests, which are critical for understanding brain disorders. Thanks to a recent study, the animal data is now in reach.
While pacemakers have treated many patients with heart rhythm disorders, their bulky design and use of wires limits their usefulness and poses a risk of heart damage or infection. Now, researchers have cut the cords, shrunk the size, and expanded the capabilities of current designs.
Researchers have developed sugar-coated gold nanoparticles to both image and destroy biofilms. In a study, they used the nanoparticles on the teeth and wounded skin of rats and mice, eliminating biofilms in as little as one minute and outperforming common antimicrobials.
The qualities of flowing blood, or hemodynamics, hold important insights into vascular diseases, but technological limitations have largely kept measurements of these properties out of reach in the clinic. Now, there may be a potential solution on the horizon.
Frequent insulin injections are an unpleasant reality for many patients with type 1 diabetes. However, new technology could create a different reality for these patients.
A beating heart makes for a formidable surgical arena, but a new robotic catheter could someday equip surgeons to operate in the cardiac environment with greater ease.
Artificially causing – or inducing – labor is becoming increasingly common, yet this practice comes with risks and its level of success is difficult to foresee. But now, new research may offer a way to help predict outcomes and improve the process.
Introducing medical devices — commonly made of materials such as titanium, silicone, or collagen — into our bodies can elicit a host of different immune responses. While some responses can harm our bodies, others can help heal them. A new study fills in a critical piece of the puzzle.